Channelopathies of skeletal muscle excitability
- PMID: 25880512
- PMCID: PMC4754081
- DOI: 10.1002/cphy.c140062
Channelopathies of skeletal muscle excitability
Abstract
Familial disorders of skeletal muscle excitability were initially described early in the last century and are now known to be caused by mutations of voltage-gated ion channels. The clinical manifestations are often striking, with an inability to relax after voluntary contraction (myotonia) or transient attacks of severe weakness (periodic paralysis). An essential feature of these disorders is fluctuation of symptoms that are strongly impacted by environmental triggers such as exercise, temperature, or serum K(+) levels. These phenomena have intrigued physiologists for decades, and in the past 25 years the molecular lesions underlying these disorders have been identified and mechanistic studies are providing insights for therapeutic strategies of disease modification. These familial disorders of muscle fiber excitability are "channelopathies" caused by mutations of a chloride channel (ClC-1), sodium channel (NaV1.4), calcium channel (CaV1.1), and several potassium channels (Kir2.1, Kir2.6, and Kir3.4). This review provides a synthesis of the mechanistic connections between functional defects of mutant ion channels, their impact on muscle excitability, how these changes cause clinical phenotypes, and approaches toward therapeutics.
© 2015 American Physiological Society.
Figures
Similar articles
-
Voltage-sensor mutations in channelopathies of skeletal muscle.J Physiol. 2010 Jun 1;588(Pt 11):1887-95. doi: 10.1113/jphysiol.2010.186874. Epub 2010 Feb 15. J Physiol. 2010. PMID: 20156847 Free PMC article. Review.
-
Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia.Neurology. 2008 Mar 4;70(10):755-61. doi: 10.1212/01.wnl.0000265397.70057.d8. Epub 2007 Sep 26. Neurology. 2008. PMID: 17898326 Free PMC article.
-
Periodic paralysis.Handb Clin Neurol. 2018;148:505-520. doi: 10.1016/B978-0-444-64076-5.00032-6. Handb Clin Neurol. 2018. PMID: 29478596 Review.
-
Pathomechanisms in channelopathies of skeletal muscle and brain.Annu Rev Neurosci. 2006;29:387-415. doi: 10.1146/annurev.neuro.29.051605.112815. Annu Rev Neurosci. 2006. PMID: 16776591 Review.
-
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies.Eur J Histochem. 2003;47(1):17-28. doi: 10.4081/803. Eur J Histochem. 2003. PMID: 12685554
Cited by
-
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia.Front Neurol. 2020 Sep 4;11:1019. doi: 10.3389/fneur.2020.01019. eCollection 2020. Front Neurol. 2020. PMID: 33013670 Free PMC article.
-
Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model.J Clin Invest. 2024 Jan 2;134(1):e173576. doi: 10.1172/JCI173576. J Clin Invest. 2024. PMID: 38165038 Free PMC article.
-
BK channels promote action potential repolarization in skeletal muscle but contribute little to myotonia.Pflugers Arch. 2024 Nov;476(11):1693-1702. doi: 10.1007/s00424-024-03005-z. Epub 2024 Aug 16. Pflugers Arch. 2024. PMID: 39150500 Free PMC article.
-
Physiotherapy Strategies in Hypokalemic Periodic Paralysis: A Case Report.Cureus. 2024 Jan 15;16(1):e52294. doi: 10.7759/cureus.52294. eCollection 2024 Jan. Cureus. 2024. PMID: 38357046 Free PMC article.
-
Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis.Brain. 2023 Apr 19;146(4):1554-1560. doi: 10.1093/brain/awac441. Brain. 2023. PMID: 36718088 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
